Skip to main content

Revance Therapeutics, Inc. - Common Stock (NQ: RVNC )

3.080 +0.010 (+0.33%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
January 11, 2015
Form SC 13G
Source: SEC/Edgar
January 08, 2015
Form 8-K
Source: SEC/Edgar
December 21, 2014
Form 8-K
Source: SEC/Edgar
November 11, 2014
Form 8-K
Source: SEC/Edgar
November 03, 2014
Form S-8
Source: SEC/Edgar
August 28, 2014
Form 8-K
Source: SEC/Edgar
August 28, 2014
Form 8-K
Source: SEC/Edgar
August 11, 2014
Form 424B4
Source: SEC/Edgar
June 18, 2014
Form EFFECT
Source: SEC/Edgar
June 17, 2014
Form FWP
Source: SEC/Edgar
June 17, 2014
Form S-1/A
Source: SEC/Edgar
June 17, 2014
Form S-1/A
Source: SEC/Edgar
June 15, 2014
Form S-1
Source: SEC/Edgar
June 05, 2014
Form 8-K
Source: SEC/Edgar
May 12, 2014
Form 8-K
Source: SEC/Edgar
March 25, 2014
Form 8-K
Source: SEC/Edgar
March 20, 2014
Form 8-K
Source: SEC/Edgar
March 04, 2014
Form 8-K
Source: SEC/Edgar
March 03, 2014
Form SC 13G
Source: SEC/Edgar
February 23, 2014
Form 8-K
Source: SEC/Edgar
February 23, 2014
Form S-8
Source: SEC/Edgar
February 13, 2014
Form 8-K
Source: SEC/Edgar
February 10, 2014
Form CT ORDER
Source: SEC/Edgar
February 05, 2014
Form 424B4
Source: SEC/Edgar
February 05, 2014
Form S-1MEF
Source: SEC/Edgar
February 04, 2014
Form EFFECT
Source: SEC/Edgar
February 04, 2014
Form CERTNAS
Source: SEC/Edgar
February 03, 2014
Form 8-A12B
Source: SEC/Edgar
February 03, 2014
Form S-1/A
Source: SEC/Edgar
February 02, 2014
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.